Clinical and demographic characteristics of children with hypertension

Hypertension

Volumn 60, Issue 4, 2012, Pages 1047-1054

  Flynn, Joseph ^a   Zhang, Ying ^b   Solar Yohay, Susan ^b   Shi, Victor ^b  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

adolescents; children; clinical trial; obesity; pediatric hypertension; primary hypertension; secondary hypertension

Indexed keywords

CHOLESTEROL; VALSARTAN;

ADOLESCENT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; BODY WEIGHT; CHILD; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; INFANT; MALE; OBESITY; RISK FACTORS;

EID: 84866550858     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.197525     Document Type: Article

References (18)

1. Robinson RF, Batisky DL, Hayes JR, Nahata MC, Mahan JD. Body mass index in primary and secondary pediatric hypertension. Pediatr Nephrol. 2004;19:1379-1384.
2. Flynn JT, Alderman MH. Characteristics of children with primary hypertension seen at a referral center. Pediatr Nephrol. 2005;20:961-966.
3. Croix B, Feig DI. Childhood hypertension is not a silent disease. Pediatr Nephrol. 2006;21:527-532.
4. Gomes RS, Quirino IG, Pereira RM, Vitor BM, Leite AF, Oliveira EA, Simões e Silva AC. Primary versus secondary hypertension in children followed up at an outpatient tertiary unit. Pediatr Nephrol. 2011; 26:441-447.
5. Kapur G, Ahmed M, Pan C, Mitsnefes M, Chiang M, Mattoo TK. Secondary hypertension in overweight and stage 1 hypertensive children: a Midwest Pediatric Nephrology Consortium report. J Clin Hypertens (Greenwich). 2010;12:34-39.
6. Flynn JT, Meyers KE, Neto JP, Meneses RdeP, Zurowska A, Bagga A, Mattheyse L, Shi V, Solar-Yohay S, Gupte J, Han G, for the Pediatric Valsartan Study Group. Effcacy and safety of the angiotensin receptor blocker valsartan in children with hypertension aged 1 to 5 years. Hypertension. 2008;52:222-228.
7. Wells T, Blumer J, Meyers KE, Neto JP, Meneses R, Litwin M, Vande Walle J, Solar-Yohay S, Shi V, Han G, for the Valsartan Pediatric Hypertension Study Group. Effectiveness and safety of valsartan in children aged 6 to 16 years with hypertension. J Clin Hypertens (Greenwich). 2011;13:357-365.
8. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555-576.
9. Centers for Disease Control and Prevention National Center for Health Statistics. 2000 CDC Growth Charts: United States. Available at: http://www.cdc.gov/growthcharts/. Accessed January 10, 2012.
10. Daniels SR, Greer FR, for the Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008;122:198-208.
11. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular fltration rate in infants, children, and adolescents. Pediatr Clin North Am. 1987;34:571-590.
12. Benjamin DK, Smith PB, Jadhav P, Gobburu JV, Murphy MD, Hasselblad V, Baker-Smith C, Califf RM, Li JS. Pediatric antihyperten-sive trial failures: analysis of end points and dose range. Hypertension. 2008;51:834-840.
13. Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ. Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics. 2004;113:475-482.
14. Steinthorsdottir SD, Eliasdottir SB, Indridason OS, Agustsdottir IM, Palsson R, Edvardsson VO. Prevalence of hypertension in 9-to 10-year-old Icelandic school children. J Clin Hypertens (Greenwich). 2011;13:774-779.
15. Sorof JM, Poffenbarger T, Franco K, Bernard L, Portman RJ. Isolated systolic hypertension, obesity, and hyperkinetic hemodynamic states in children. J Pediatr. 2002;140:660-666.
16. Daniels SR, Arnett DK, Eckel RH, Gidding SS, Hayman LL, Kumanyika S, Robinson TN, Scott BJ, StJeor S, Williams CL. Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation. 2005;111:1999-2012.
17. Hunley TE, Ma L-J, Kon V. Scope and mechanisms of obesity-related renal disease. Curr Opin Nephrol Hypertens. 2010;19:227-234.
18. McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr. 2007;150:640-644.